TRYP Therapeutics
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Assessment of Psilocybin (TRP-8802) in Concert With Psychotherapy in Patients With Irritable Bowel Syndrome (IBS) (NCT06206265) | TRYP Therapeutics | 2024-01-17 |
| Evaluation of Psilocybin (TRP-8802) in the Treatment of Binge Eating Disorder (NCT05035927) | TRYP Therapeutics | 2022-03-16 |
Track TRYP Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.